Making the price tag more justifiable.
https://newsroom.csl.com/2025-02-07-CSL-Behrings-Gene-Therapy-HEMGENIX-R-etranacogene-dezaparvovec-drlb-Four-Years-Post-Infusion-Data-Continue-to-Show-Sustained-Efficacy-and-Safety-in-Adults-with-Hemophilia-B
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$239.04 |
Change
-1.170(0.49%) |
Mkt cap ! $115.7B | |||
| Open | High | Low | Value | Volume |
| $239.78 | $239.88 | $236.80 | $44.48M | 186.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12 | $239.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $239.05 | 3 | 1 |
View Market Depth
| Last trade - 13.04pm 23/06/2025 (20 minute delay) ? |
| CSL (ASX) Chart |